Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells

被引：0
|
作者：
Feifei Xu
Fengliang Wang
Ting Yang
Yuan Sheng
Ting Zhong
Yun Chen
机构：
[1] Nanjing Medical University,School of Pharmacy
[2] Nanjing Maternity and Child Health Care Hospital,undefined
来源：
Cancer Cell International | / 14卷
关键词：
Multi-drug Resistance Acquisition (MDR); P-glycoprotein (P-gp); Drug-specific; Doxorubicin (DOX); Paclitaxel (PTX);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Side population cells and drug resistance in breast cancer
    Wang, Meijian
    Wang, Yaqi
    Zhong, Jun
    MOLECULAR MEDICINE REPORTS, 2015, 11 (06) : 4297 - 4302
  • [42] The Breast Cancer Stem Cells Traits and Drug Resistance
    Zheng, Qinghui
    Zhang, Mengdi
    Zhou, Fangfang
    Zhang, Long
    Meng, Xuli
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [43] Penetration characteristics of paclitaxel and doxorubicin in multilayers of cancer cells
    Lee, Joo-Ho
    Al-Abd, Ahmed M.
    Kang, Choon-Mo
    Kuh, Hyo-Jeong
    DRUG METABOLISM REVIEWS, 2006, 38 : 90 - 91
  • [44] Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
    Schwonzen, M
    Kurbacher, CM
    Mallmann, P
    ANTI-CANCER DRUGS, 2000, 11 (09) : 681 - 685
  • [45] Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
    Gehl, J
    Boesgaard, M
    Paaske, T
    Jensen, BV
    Dombernowsky, P
    ANNALS OF ONCOLOGY, 1996, 7 (07) : 687 - 693
  • [46] Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
    Cheryl A Sherman-Baust
    Kevin G Becker
    William H Wood III
    Yongqing Zhang
    Patrice J Morin
    Journal of Ovarian Research, 4
  • [47] Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
    Sherman-Baust, Cheryl A.
    Becker, Kevin G.
    Wood, William H.
    Zhang, Yongqing
    Morin, Patrice J.
    JOURNAL OF OVARIAN RESEARCH, 2011, 4
  • [48] Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells
    Sivakumar Vijayaraghavalu
    Vinod Labhasetwar
    Drug Delivery and Translational Research, 2018, 8 : 1289 - 1299
  • [49] Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells
    Vijayaraghavalu, Sivakumar
    Labhasetwar, Vinod
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2018, 8 (05) : 1289 - 1299
  • [50] Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells
    Cristina Alexandra Ciocan-Cartita
    Ancuta Jurj
    Oana Zanoaga
    Roxana Cojocneanu
    Laura-Ancuta Pop
    Alin Moldovan
    Cristian Moldovan
    Alina Andreea Zimta
    Lajos Raduly
    Cecilia Pop-Bica
    Mihail Buse
    Liviuta Budisan
    Piroska Virag
    Alexandru Irimie
    Sandra Martha Gomes Dias
    Ioana Berindan-Neagoe
    Cornelia Braicu
    Journal of Experimental & Clinical Cancer Research, 39
12345